Basilea Pharmaceutica (XSWX:BSLN) Net Change in Cash : CHF-43.5 Mil (TTM As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Basilea Pharmaceutica's Net Change in Cash for the six months ended in Jun. 2024 was CHF5.1 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-43.5 Mil.

Basilea Pharmaceutica Net Change in Cash Historical Data

The historical data trend for Basilea Pharmaceutica's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Net Change in Cash Chart

Basilea Pharmaceutica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-62.86

-44.79

-11.30

53.61

-44.25

Basilea Pharmaceutica Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Change in Cash	Get a 7-Day Free Trial															-8.09	61.71	4.38	-48.63	5.15

Basilea Pharmaceutica Net Change in Cash Calculation

Basilea Pharmaceutica's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	14.245	+	-1.034	+	-57.305	+	-0.151
	=	-44.2

Basilea Pharmaceutica's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 17.92 + 0.261 + -13.142 + 0.109

= 5.1

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-43.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Basilea Pharmaceutica Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Basilea Pharmaceutica's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Basilea Pharmaceutica Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » Net Change in Cash

Comparable Companies

XSWX:IDIA XSWX:MOLN XSWX:NWRN XSWX:XLS XSWX:SANN XSWX:RLF XSWX:ADXN VRTX REGN ASX:CSL XKRX:207940 XBRU:UCB ALNY XBRU:ARGX XKRX:068270 BNTX BGNE MRNA SMMT UTHR

Traded in Other Exchanges

BPMUF:USA BSLNz:UK 0QNA:UK

Address

Hegenheimermattweg 167b, Allschwil, CHE, 4123

Website

https://www.basilea.com

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica Headlines

No Headlines